1. Home
  2. JOE vs APLS Comparison

JOE vs APLS Comparison

Compare JOE & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JOE
  • APLS
  • Stock Information
  • Founded
  • JOE 1936
  • APLS 2009
  • Country
  • JOE United States
  • APLS United States
  • Employees
  • JOE N/A
  • APLS N/A
  • Industry
  • JOE Homebuilding
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JOE Real Estate
  • APLS Health Care
  • Exchange
  • JOE Nasdaq
  • APLS Nasdaq
  • Market Cap
  • JOE 2.7B
  • APLS 2.9B
  • IPO Year
  • JOE N/A
  • APLS 2017
  • Fundamental
  • Price
  • JOE $48.08
  • APLS $24.54
  • Analyst Decision
  • JOE
  • APLS Buy
  • Analyst Count
  • JOE 0
  • APLS 19
  • Target Price
  • JOE N/A
  • APLS $33.63
  • AVG Volume (30 Days)
  • JOE 169.8K
  • APLS 2.1M
  • Earning Date
  • JOE 10-22-2025
  • APLS 10-30-2025
  • Dividend Yield
  • JOE 1.16%
  • APLS N/A
  • EPS Growth
  • JOE 16.57
  • APLS N/A
  • EPS
  • JOE 1.42
  • APLS N/A
  • Revenue
  • JOE $426,624,000.00
  • APLS $754,649,000.00
  • Revenue This Year
  • JOE N/A
  • APLS $21.75
  • Revenue Next Year
  • JOE N/A
  • APLS N/A
  • P/E Ratio
  • JOE $33.90
  • APLS N/A
  • Revenue Growth
  • JOE 10.09
  • APLS 20.02
  • 52 Week Low
  • JOE $40.19
  • APLS $16.10
  • 52 Week High
  • JOE $60.10
  • APLS $35.72
  • Technical
  • Relative Strength Index (RSI)
  • JOE 44.87
  • APLS 51.65
  • Support Level
  • JOE $46.37
  • APLS $23.10
  • Resistance Level
  • JOE $47.87
  • APLS $25.73
  • Average True Range (ATR)
  • JOE 1.14
  • APLS 1.03
  • MACD
  • JOE 0.05
  • APLS 0.13
  • Stochastic Oscillator
  • JOE 48.25
  • APLS 58.85

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: